Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Timber Pharmaceuticals Inc (NY: TMBR ) N/A UNCHANGED Last Price Updated: 8:00 PM EST, Nov 28, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Timber Pharmaceuticals Inc < Previous 1 2 3 4 5 Next > Timber Pharmaceuticals Receives Court Approval of All First Day Motions to Support Business Operations & Discloses Communication From NYSE American November 28, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance September 18, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. - TMBR August 29, 2023 From Kahn Swick & Foti, LLC Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023 August 28, 2023 Via Benzinga Crude Oil Falls; Nikola Shares Plummet August 21, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded down 0.16% to 34,446.91 while the NASDAQ rose 1.52% to 13,492.73. The S&P... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session August 21, 2023 Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 21, 2023 Via Benzinga Why Timber Pharmaceuticals Stock Is Skyrocketing Today August 21, 2023 Timber Pharmaceuticals, Inc. (NYSE: TMBR) has Via Benzinga Dow Tumbles Over 100 Points; Timber Pharmaceuticals Shares Spike Higher August 21, 2023 U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded down 0.40% to 34,362.93 while the NASDAQ rose 0.78% to 13,394.60. The S&P 500,... Via Benzinga Topics Stocks Exposures US Equities TMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to Shareholders August 21, 2023 From Halper Sadeh LLC Via Business Wire Why Is Skillz (SKLZ) Stock Up 20% Today? August 21, 2023 Skillz (SKLZ) stock is taking off on Monday after the mobile gaming company announced plans for a share repurchase program. Via InvestorPlace Why Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today? August 21, 2023 Timber Pharmaceuticals (TMBR) stock is undergoing a rally on Monday after announcing that Leo US is acquiring it in a $36 million deal. Via InvestorPlace US Stocks Mostly Higher; Nasdaq Jumps 100 Points August 21, 2023 U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. Following the market opening Monday, the Dow traded down 0.11% to 34,461.22 while the... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Pre-Market Session August 21, 2023 Via Benzinga Timber Pharmaceuticals to be Acquired by LEO Pharma August 21, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire 12 Health Care Stocks Moving In Friday's After-Market Session August 18, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session August 18, 2023 Via Benzinga Timber Pharmaceuticals Discloses Communication From NYSE American July 03, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Timber Pharmaceuticals to Present Interim Analyses from Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis June 20, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 06, 2023 Via Benzinga Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket June 06, 2023 Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading. Via Benzinga Dow Drops Over 100 Points; Crude Oil Rises June 05, 2023 U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Monday. The Dow traded down 0.33% to 33,651.23 while the NASDAQ rose 0.30% to 13,279.88. The S&P 500, also... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 05, 2023 Via Benzinga Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 05, 2023 Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. Via Benzinga Nasdaq Rises 70 Points; ISM Services PMI Drops In May June 05, 2023 U.S. stocks traded mixed midway through trading, with Nasdaq Composite gaining around 70 points on Monday. The Dow traded down 0.21% to 33,691.13 while the NASDAQ rose 0.54% to 13,312.65. The S&P 500,... Via Benzinga Timber Pharmaceuticals’ (NYSE American: TMBR) Phase 3 ASCEND Study for TMB-001: A Leap Forward in Congenital Ichthyosis Treatment June 05, 2023 Significant Progress in Timber Pharmaceuticals' Phase 3 ASCEND Study Timber Pharmaceuticals (NYSE American: TMBR), a clinical-stage biopharmaceutical company specializing in Via Spotlight Growth Exposures Product Safety 12 Health Care Stocks Moving In Monday's Pre-Market Session June 05, 2023 Via Benzinga Why Are Timber Pharmaceuticals Shares Trading Higher Today June 05, 2023 The FDA has granted dermal carcinogenicity (CARC) waiver for Timber Pharmaceuticals Inc's (NYSE: TMBR) TMB-001, a topical isotretinoin formulated using the company's patented IPEG delivery system. Via Benzinga Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001 June 05, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results May 15, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
